Journal article
Neoadjuvant programmed cell death 1 blockade combined with chemotherapy for resectable esophageal squamous cell carcinoma
Abstract
BACKGROUND: Programmed cell death 1 (PD-1) blockade induces tumor regression in patients with advanced esophageal squamous cell carcinoma (ESCC); however, little is known about the efficacy of PD-1 blockade as neoadjuvant therapy in resectable ESCC. We aim to assess the safety and feasibility of using the combination of neoadjuvant PD-1 blockade with chemotherapy in patients with ESCC.
METHODS: Patients with previously untreated, resectable …
Authors
Yang W; Xing X; Yeung S-CJ; Wang S; Chen W; Bao Y; Wang F; Feng S; Peng F; Wang X
Journal
Journal for ImmunoTherapy of Cancer, Vol. 10, No. 1,
Publisher
BMJ
Publication Date
January 2022
DOI
10.1136/jitc-2021-003497
ISSN
2051-1426